NGeneBio
Latest round
- Series B
Last raised
- Nov 2018
Total raised
- $10M
Investors
- 8
About NGeneBio
Founded in 2015 and based in Seoul, South Korea, NGeneBio develops in vitro diagnostics (IVD) and companion diagnostics (CDx) products for hereditary breast and ovarian cancer.444 million shares at KRW 14,000 per share on the KOSDAQ
Who invested in NGeneBio
8 investors across 2 rounds
See all investors in NGeneBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NGeneBio
Who invested in NGeneBio?
NGeneBio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NGeneBio raised?
NGeneBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NGeneBio last raise money?
NGeneBio's most recent round on record is a Series B, in Nov 2018.
What does NGeneBio do?
Founded in 2015 and based in Seoul, South Korea, NGeneBio develops in vitro diagnostics (IVD) and companion diagnostics (CDx) products for hereditary breast and ovarian cancer.
Where is NGeneBio headquartered?
NGeneBio is headquartered in Seoul, South Korea.
Which VCs invest in companies like NGeneBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at NGeneBio's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like NGeneBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.